E. coli biotin ligase
(BirA) is highly specific in covalently attaching biotin to the 15 amino
acid AviTag peptide. This recombinant protein was biotinylated in vivo
by AviTag-BirA technology, which method is BriA catalyzes amide linkage
between the biotin and the specific lysine of the AviTag.
The tag type will be
determined during production process. If you have specified tag
type, please tell us and we will develop the specified tag
preferentially.
產(chǎn)品提供形式:
Lyophilized powder Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
復(fù)溶:
We recommend that this vial be briefly centrifuged prior
to opening to bring the contents to the bottom. Please reconstitute
protein in deionized sterile water to a concentration of 0.1-1.0
mg/mL.We recommend to add 5-50% of glycerol (final concentration) and
aliquot for long-term storage at -20℃/-80℃. Our default final
concentration of glycerol is 50%. Customers could use it as reference.
儲存條件:
Store at -20°C/-80°C upon receipt, aliquoting is necessary for
mutiple use. Avoid repeated freeze-thaw cycles.
保質(zhì)期:
The shelf life is related to many factors, storage state,
buffer ingredients, storage temperature and the stability of the protein
itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The
shelf life of lyophilized form is 12 months at -20°C/-80°C.
貨期:
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our
proteins are default shipped with normal blue ice packs, if you
request to ship with dry ice, please communicate with us in advance
and extra fees will be charged.
注意事項:
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane. Can form functional homotetrameric channels and heterotetrameric channels that contain variable proportions of KCNA1, KCNA2, KCNA4, KCNA5, and possibly other family members as well; channel properties depend on the type of alpha subunits that are part of the channel. Channel properties are modulated by cytoplasmic beta subunits that regulate the subcellular location of the alpha subunits and promote rapid inactivation. Homotetrameric channels display rapid activation and slow inactivation. May play a role in regulating the secretion of insulin in normal pancreatic islets. Isoform 2 exhibits a voltage-dependent recovery from inactivation and an excessive cumulative inactivation.
基因功能參考文獻(xiàn):
Molecular dynamics simulations are employed to determine the inhibitory mechanisms of three drugs, 5-(4-phenoxybutoxy)psoralen (PAP-1), vernakalant, and flecainide, on the voltage-gated K(+) channel Kv1.5, a target for the treatment of cardiac arrhythmia. PMID: 29652491
This study adds insights to the functional impact of KCNA5 mutations in modulating atrial contractile functions. PMID: 28803858
In addition, as IKur is an atrial-specific channel and a number of IKur-selective blockers have been developed as anti-AF agents, this study also helps to understand some contradictory results on both pro- and anti-arrhythmic effects of blocking IKur. PMID: 28622331
our finding indicated that KCNA5 protein may interact with Cav-1, thereby contributing to the proliferation and early transformation of mammary cells. PMID: 27075359
Putative binding sites for arachidonic acid on the human cardiac Kv 1.5 channel PMID: 26292661
Studies demonstrate that DNA hypermethylation contributes to epigenetic repression of the KCNA5 locus and that the resulting suppression of the Kv1.5 ion channel supports cancer cell proliferation. PMID: 26573141
Kv1.5 expression is increased in osteosarcoma cells and tissues and shRNA mediated silencing of Kv1.5 results in cell proliferation inhibition, cell cycle arrest, and induces cell apoptosis. PMID: 26569226
Direct interaction with specific amino acids underlies the blocking action of propofol on voltage-gated hKv1.5 channel. PMID: 26256861
demonstrate that PK treatment cleaved mature membrane-bound (75kDa) Kv1.5 channels at a single locus in the S1-S2 linker, producing 42-kDa N-terminal fragments and 33-kDa C-terminal fragments PMID: 26874203
These results indicate that CHIP decreases the Kv1.5 protein level and functional channel by facilitating its degradation in concert with chaperone Hsc70 PMID: 26232501
The expression of Kv1.5 channel protein changes with atrial fibrillation but not with age, rheumatic heart diseases, and sex in atrial fibrillation. PMID: 25918274
One KCNA5 variant, H463R, was a novel mutation; the histidine at codon 463 is located in the S5-pore loop, in the vicinity of the pore of KV1.5 subunit. The other variant, T527M, showed a gain-of-function effect with an enhanced steady-state activation. PMID: 26129877
The KCNA5 promoter is marked in cancer cells with PcG-dependent chromatin repressive modifications that increase in hypoxia. PMID: 25435365
Mutations in KCNA5 gene is not associated with pulmonary arterial hypertension. PMID: 24936649
Protein kinase C inhibition results in a Kv 1.5 and Kv beta 1.3 pharmacology closer to Kv 1.5 channels PMID: 24946104
Data do not indicate an important role of potassium voltage-gated channel shaker-related subfamily member 5 (KCNA5) as a sclerosis (SSc)-susceptibility factor or as a pulmonary arterial hypertension (PAH)-development genetic marker for SSc patients. PMID: 23270786
These results indicate that low temperature exposure stabilizes the protein in the cellular organelles or on the plasma membrane, and modulates its maturation and trafficking, thus enhancing the currents of hKv1.5 and its trafficking defect mutants. PMID: 24663680
Kv1.5 is a determinant of human B cell proliferation and migration, thereby identifying this channel as a new target for immunomodulation. PMID: 23847097
Results identified gain and loss of function mutations which lead to increased and decreased potassium currents enhancing AF. PMID: 23264583
AMPK is a potent regulator of Kv1.5. AMPK inhibits Kv1.5 presumably in part by activation of Nedd4- 2 with subsequent clearance of channel protein from the cell membrane. PMID: 23221389
Incretin regulation of beta-cell function involves the acetylation of Kv1.5. PMID: 23390957
Kv1.5 may play an important role in oxidative vascular endothelial injury PMID: 23185428
Ethanol prologned the action potential duration in isolated myocardium, which may be due to inhibition of Kv1.5 channel currents. PMID: 21681339
The experiments disclose a completely novel function of beta-catenin, i.e. the regulation of Kv1.5 channel activity. PMID: 22166221
In order to substantiate a possible relation between K(v1.5) and FHL1C, a pull-down assay was performed. PMID: 22053194
Our data implicate abnormal atrial repolarization control due to variable TK signaling as a mechanism in familial AF and thereby suggest a role for modulation of this pathway in AF and its treatment. PMID: 20638934
In Kv1.5 H+ and Ni2+ differentially enhance a slow inactivation process that involves at least two inactivated states and that resting inactivation is probably a close variant of slow inactivation. PMID: 20581043
an association was found solely for Pulmonary arterial hypertension associated with Systemic Sclerosis in KCNA5 ((potassium voltage-gated channel subfamily A member 5) rs10744676 variants PMID: 20556823
Kv1.5 channel is blocked by diphenyl phosphine oxide-1 PMID: 20184887
KCNA5 T527M mutation exerted a predominant negative effect on potassium currents but no effect on the subcellular location of the encoded ion channel. PMID: 20646426
Biolistically introduced exogenous voltage-gated potassium channel, Kv1.5, is functional and, like endogenous Kv1.5, localizes to the intercalated disc, where it is expressed at the surface of that structure. PMID: 20357183
Anandamide structure may a determinant of cannabinoid receptor-independent modulation. PMID: 20133392
Data support a role for the T1 domain in channel kinetics as well as in KCNA5 channel subcellular localization. PMID: 20018952
Overexpression of Kv1.5 is associated with cancer. PMID: 20025600
In the absence of potassium ion, significant N-methyl-D-glucamine (NMDG)-positive currents could be recorded from human embryonic kidney cells expressing Kv3.1 or Kv3.2b channels and Kv1.5 Arg487Tyr/Val, but not wild-type channels. PMID: 19332619
These findings expand the spectrum of mutations in KCNA5 linked to atrial fibrillation (AF) and provide new insight into the molecular mechanism involved in AF. PMID: 19343045
characterization of a truncated form of Kv1.5 PMID: 12021261
Modulation by protein kinase C activation: role of the Kvbeta1.2 subunit. PMID: 12130714
co-localization of Kv1.5 with PSD95 at the cell surface is similarly independent of the canonical PDZ-binding motif PMID: 12435606
Reduction in the activation energy for the inactivation transition from the open state underlies the inhibition of hKv1.5 Na(+) current at low pH. PMID: 12601085
Kv1.5 potassium channel mRNA expression correlates with glioma entities and malignancy grades; expression is high in astrocytomas, moderate in oligodendrogliomas, and low in glioblastomas. PMID: 12850541
multiple isoforms of SAP97 were identifed in human heart atrium specimens; isoforms were found to co-immunoprecipiate with hKv1.5; isoforms were found to have distinct effect on hKv1.5 current and spatial channel organization PMID: 12970345
the destabilization or bending of the S6 alpha-helix of KV1.5 caused by the PXP motif apparently creates a flexible "hinge" that allows movement of the lower S6 segment during channel gating and opening PMID: 13679372
No electrical remodeling is evident in Kv1.5DN-expressing ventricular myocytes, and the (Kv1.5DN-induced) elimination of IK,slow1 does not result in spontaneous ventricular arrhythmias. PMID: 14527939
an examination of the effect of K channel blocker S0100176) on the structure of the Kv1.5 channel PMID: 14578345
Overexpression of the human KCNA5 gene increases K+ currents (i.e., K+ efflux or loss), accelerates apoptotic volume decrease (AVD), increases caspase-3 activity, and induces apoptosis PMID: 15140747
Heterologously expressed human pulmonary arterial smooth muscle cells (PASMC) Kv1.5 generated an O2- and correolide-sensitive I(K) like that in resistance PASMCs. PMID: 15217912
There is a central role for developmentally regulated ductus arteriosus SMC O2-sensitive Kv channels in the functional closure of the DA. PMID: 15353504
This suggests that for Kv channels, the coupling between voltage sensing and gating reflects primarily an intrasubunit interaction. PMID: 15623896
P. 142: "An aligment of KCNA5 among human, mouse, and rat shows 86% amino acid identity, and no monogenicc human arrhythmia syndrome has been linked to KCNA5" PMID: 15735608
顯示更多
收起更多
相關(guān)疾?。?/div>
Atrial fibrillation, familial, 7 (ATFB7)
亞細(xì)胞定位:
Cell membrane; Multi-pass membrane protein.
蛋白家族:
Potassium channel family, A (Shaker) (TC 1.A.1.2) subfamily, Kv1.5/KCNA5 sub-subfamily